2023
DOI: 10.1016/j.bcp.2023.115680
|View full text |Cite
|
Sign up to set email alerts
|

Cryo-EM structures of actin binding proteins as tool for drug discovery

Christian Dahlstroem,
Themistoklis Paraschiakos,
Han Sun
et al.
Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
2
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
(2 citation statements)
references
References 96 publications
0
2
0
Order By: Relevance
“…Therefore, a not-so-uncommon opinion that the actin cytoskeleton is well understood is far from being accurate, as new functionalities of ABPs (e.g., processive pointed end actin polymerization; Kudryashova et al, 2022) are discovered regularly, while most are not sufficiently understood.Similarly, the therapeutic potential of ABPs has been barely tapped. In recent years, many ABPs have been considered as promising therapeutic targets in various diseases, such as cancer and asthma (Yin et al, 2019;Dahlstroem et al, 2023). For example, Wiskott-Aldrich syndrome protein (WASP) and WASP-interacting protein are tumor suppressors in T cell lymphoma; therefore, corresponding inhibitors could have a potent therapeutic effect (Menotti et al, 2019).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…Therefore, a not-so-uncommon opinion that the actin cytoskeleton is well understood is far from being accurate, as new functionalities of ABPs (e.g., processive pointed end actin polymerization; Kudryashova et al, 2022) are discovered regularly, while most are not sufficiently understood.Similarly, the therapeutic potential of ABPs has been barely tapped. In recent years, many ABPs have been considered as promising therapeutic targets in various diseases, such as cancer and asthma (Yin et al, 2019;Dahlstroem et al, 2023). For example, Wiskott-Aldrich syndrome protein (WASP) and WASP-interacting protein are tumor suppressors in T cell lymphoma; therefore, corresponding inhibitors could have a potent therapeutic effect (Menotti et al, 2019).…”
mentioning
confidence: 99%
“…Similarly, the therapeutic potential of ABPs has been barely tapped. In recent years, many ABPs have been considered as promising therapeutic targets in various diseases, such as cancer and asthma (Yin et al, 2019;Dahlstroem et al, 2023). For example, Wiskott-Aldrich syndrome protein (WASP) and WASP-interacting protein are tumor suppressors in T cell lymphoma; therefore, corresponding inhibitors could have a potent therapeutic effect (Menotti et al, 2019).…”
mentioning
confidence: 99%